GENOMICS
212 results
GENOMICS
-
Billions of people depend upon what farmers do. And so will billions more. In the next few decades, farmers will have to grow as much food as they have in the past 10, 000 years – combined. It is our purpose to help farmers do exactly that. To produce more food. To produce more with less, conserving resources like soil and water. And to improve lives. Monsanto is driven by a global commitment to sustainable agricultural production. This commitment includes bringing technologies to farmers that improve their lives by helping them be more productive while using fewer resources -- leading to a reduced overall effect on the environment.
-
We do this by selling seeds, traits developed through biotechnology, and crop protection chemicals. Monsanto is an agricultural company. Farmers around the world use our innovative products to address on-farm challenges and reduce agriculture's overall impact on our environment. The Monsanto company works for the world's food producers, delivering products and solutions to help them reach their goals in ways that meet the world's growing food and fiber needs, conserve natural resources, and improve the environment.
-
-
By using this commitment to drive our actions, we believe we are creating a positive impact on our world. That's why, in addition to developing our own products, we also partner and collaborate with others to develop technologies for farmers. We also license our biotech traits and germplasm to other seed companies, giving farmers the opportunity to purchase seed technologies in the brands they choose.
-
If there were one word to explain what Monsanto is about, it would have to be farmers It is our purpose to help them meet the needs of a growing population by selling seeds, traits, and crop protection chemicals
-
But we can't do this alone. That's why, in addition to developing our own products, we also partner and collaborate with others to develop technologies for farmers. We also license our biotech traits and germplasm to other seed companies, giving farmers the opportunity to purchase seed technologies in the brands they choose. Monsanto is driven by a global commitment to sustainable agricultural production.
-
If there were one word to explain what Monsanto is about, it would have to be farmers. Billions of people depend upon what farmers do. And so will billions more. In the next few decades, farmers will have to grow as much food as they have in the past 10, 000 years – combined. It is our purpose to help farmers do exactly that. To produce more food. To produce more with less, conserving resources like soil and water. And to improve lives. We do this by selling seeds, traits developed through biotechnology, and crop protection chemicals. But we can't do this alone.
-
Billions of people depend upon what farmers do. And so will billions more. In the next few decades, farmers will have to grow as much food as they have in the past 10, 000 years – combined. It is our purpose to help farmers do exactly that. To produce more food. To produce more with less, conserving resources like soil and water. And to improve lives. We do this by selling seeds, traits developed through biotechnology, and crop protection chemicals.
-
If there were one word to explain what Monsanto is about, it would have to be farmers It is our purpose to help them meet the needs of a growing population by selling seeds, traits, and crop protection chemicals
-
Monsanto is driven by a global commitment to sustainable agricultural production. This commitment includes bringing technologies to farmers that improve their lives by helping them be more productive while using fewer resources -- leading to a reduced overall effect on the environment. By using this commitment to drive our actions, we believe we are creating a positive impact on our world.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Greater Arkansas Chapter of JDRF was founded in 1998 by parents of children with type 1 diabetes to raise money that will fund research to find a cure for diabetes, and to provide support for children and adults with the disease, and their families. The Mission of the Juvenile Diabetes Research Foundation International is to find a cure for diabetes and its complications through the support of research and research related education.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JDRF is the only organization of its kind devoted to finding a cure for adults and children living with type 1 diabetes. We concentrate our support on advancing the most promising work of researchers, scientists, physicians, academic medical centers, and more across the globe. Our dedication to finding a cure focuses not just on this long-term need, but also on improving everyone's life today by working to reduce the life-threatening aspects of diabetes and providing emotional support and practical resources for the day-to-day issues surrounding the disease.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JUVENILE DIABETES RESEARCH FOUNDATION
IN, 46240 INDIANAPOLIS, 8440 WOODFIELD CROSSING BLVD, SUITE 201
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JUVENILE DIABETES RESEARCH FOUNDATION
GA, 30305 ATLANTA, 3525 PIEDMONT ROAD, NE BUILDING 6, SUITE 300
The Georgia Chapter is here to assist those affected by type 1 diabetes by offering one-to-one connections, providing useful resources, hosting educational programs and advancing the search for a cure with an active advocacy program. Through the success of our premier fundraising events including, Walk to Cure, Hope for a Cure Gala, Ride to Cure and Rock the Cure, the Georgia Chapter proudly raised over $4.6 million for diabetes research in 2009. The Juvenile Diabetes Research Foundation (JDRF) is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. Since our founding in 1970 by parents of children with type 1 diabetes our mission has remained constant, to find a cure.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
